Oncology's trials

descriptionPublicationkeyboard_double_arrow_right Article 01 Aug 2003 English Publisher:Springer Science and Business Media LLCJournal:Nature Reviews Drug Discovery, volume 2, pages 609-610 (issn: 1474-1776, eissn: 1474-1784,

Copyright policy )

Authors: Bruce, Booth; Robert, Glassman; Philip, Ma;

doi: 10.1038/nrd1158

pmid: 12908467

Oncology's trials

- Summary
- Subjects
- Metrics

Related Organizations

McKinsey & Company
United States

Keywords

Clinical Trials as Topic, Drug Industry, Humans, Antineoplastic Agents, Drug Approval

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	74
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 1%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%